Table 1.
Stroke (days) | GF (%) | Tc-Ts (h) | Tc (h) | TG1 (h) | TG2+M (h) | Experimental interval (h) |
---|---|---|---|---|---|---|
Nonstroke | 20 | 14.4 | 19 | 12.6 | 1.79 | 16 |
2 | 23.6* | 9.2* | 11.5* | 7.5* | 1.79 | 11 |
4 | 30*,# | 10.1*,# | 12.5*,# | 8.3*,# | 1.80 | 11 |
7 | 31.*,# | 11.4*,# | 15.3*,# | 9.6*,# | 1.78 | 13 |
14 | 24 | 14.9# | 19.7# | 13# | 1.79 | 16 |
IdU, 5-iodo-2′-deoxyuridine; SVZ, subventricular zone.
P<0.05 compared with rats without stroke.
P<0.05 compared with 2 days after stroke.
Experimental interval indicates a perfuse time after initial IdU injection.